Early research (Phase 1)Study completedNCT00001088
What this trial is testing
A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40